BANK OF AMERICA CORP /DE/
BankPosition in LGND — Ligand Pharmaceuticals Inc
CIK 70858
CHARLOTTE, NC
Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$53,845,614
+$22,327,869 QoQ
Shares Held
170,349
+7.9% QoQ
Ownership
0.854%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 27%
Shared 0%
None 73%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. LGND ranks #46 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,845,614 | 170,349 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,517,745 | 157,865 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $22,720,350 | 120,169 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $21,683,526 | 122,409 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $13,165,050 | 115,808 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,565,201 | 100,487 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,512,086 | 107,439 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,500,039 | 104,906 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,632,434 | 102,450 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,945,846 | 149,738 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,049,031 | 112,700 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,421,085 | 107,161 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,405,938 | 88,848 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,041,259 | 82,127 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,961,034 | 74,267 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $8,426,545 | 97,858 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,724,771 | 75,373 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,967,436 | 124,166 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,167,090 | 85,246 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $10,835,745 | 77,776 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,755,740 | 81,986 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $11,719,282 | 76,873 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $22,187,878 | 223,106 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $21,104,033 | 221,402 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,006,276 | 160,986 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,275,279 | 127,548 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||